Al's Comment:

Very good early results reported.  The interesting things about this treatment are:

1. that it might work on patients whose tumors are MGMT unmethylated - a condition which usually makes them resistant to Temodar.

2. It may work after Avastin fails. Up until now, there hasn't been much success on patients after Avastin failure.


Posted on: 07/23/2016

DelMar Pharmaceuticals Announces Presentation at the European Association of Neuro-Oncology (EANO) Annual Meeting in October 2016

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!